Overview
Ri Cui practices practicing medicine in Wenzhou, China.
Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Colorectal Cancer, and Familial Colorectal Cancer.
They are actively involved in clinical research, co-authoring 68 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ri Cui
Is Ri Cui a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Ri Cui is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ri Cui participate in research or clinical trials?
Yes. Ri Cui has published 68 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Ri Cui's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerCui isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal Cancer
- Lung CancerCui isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)